Expression and clinical role of protein of regenerating liver (PRL) phosphatases in ovarian carcinoma

International Journal of Molecular Sciences

Volumn 12, Issue 2, 2011, Pages 1133-1145

  Reich, Reuven ^a   Hadar, Shany ^a   Davidson, Ben ^b,c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Effusion; Metastasis; Ovarian carcinoma; PRL phosphatases; Survival

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE; LAMININ; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PACLITAXEL; PHOSPHATASE; PHOSPHOLIPASE D; PROTEIN OF REGENERATING LIVER; PROTEIN OF REGENERATING LIVER 1; PROTEIN OF REGENERATING LIVER 2; PROTEIN OF REGENERATING LIVER 3; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; MEMBRANE PROTEIN; PROTEIN TYROSINE PHOSPHATASE; PTP4A1 PROTEIN, HUMAN; PTP4A2 PROTEIN, HUMAN; PTP4A3 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVERALL SURVIVAL; PERITONEUM EXUDATE; PLEURA EFFUSION; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CARCINOMA; GENETICS; METABOLISM; MIDDLE AGED; OVARIAN NEOPLASMS; TUMOR CELL LINE;

ADULT; AGED; CARCINOMA; CELL CYCLE PROTEINS; CELL LINE, TUMOR; FEMALE; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PROGNOSIS; PROTEIN TYROSINE PHOSPHATASES; TUMOR MARKERS, BIOLOGICAL;

EID: 79952256593     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12021133     Document Type: Article

References (33)

1. Alonso, A.; Sasin, J.; Bottini, N.; Friedberg, I.; Friedberg, I.; Osterman, A.; Godzik, A.; Hunter, T.; Dixon, J.; Mustelin, T. Protein tyrosine phosphatases in the human genome. Cell 2004, 117, 699-711.
2. Stoker, A.W. Protein tyrosine phosphatases and signaling. J. Endocrinol. 2005, 185, 19-33.
3. van Huijsduijnen, R.H.; Bombrun, A.; Swinnen, D. Selecting protein tyrosine phosphatases as drug targets. Drug Discov. Today 2002, 7, 1013-1019.
4. Parsons, R. Phosphatases and tumorigenesis. Curr. Opin. Oncol. 1998, 10, 88-91.
5. Mohn, K.L.; Laz, T.M.; Hsu, J.C.; Melby, A.E.; Bravo, R.; Taub, R. The immediate-early growth response in regenerating liver and insulin-stimulated H-35 cells: comparison with serum-stimulated 3T3 cells and identification of 41 novel immediate-early genes. Mol. Cell Biol. 1991, 11, 381-390.
6. Diamond, R.H.; Cressman, D.E.; Laz, T.M.; Abrams, C.S.; Taub, R. PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Mol. Cell Biol. 1994, 14, 3752-3762.
7. Montagna, M.; Serova, O.; Sylla, B.S.; Feunteun, J.; Lenoir, G.M. A 100-kb physical and transcriptional map around the EDH17B2 gene: identification of three novel genes and a pseudogene of a human homologue of the rat PRL-1 tyrosine phosphatase. Hum. Genet. 1995, 96, 532-538.
8. Cates, C.A.; Michael, R.L.; Stayrook, K.R.; Harvey, K.A.; Burke, Y.D.; Randall, S.K.; Crowell, P.L.; Crowell, D.N. Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases. Cancer Lett. 1996, 110, 49-55.
9. Zhao, Z.; Lee, C.C.; Monckton, D.G.; Yazdani, A.; Coolbaugh, M.I.; Li, X.; Bailey, J.; Shen, Y.; Caskey, C.T. Characterization and genomic mapping of genes and pseudogenes of a new human protein tyrosine phosphatase. Genomics 1996, 35, 172-181.
10. Matter, W.F.; Estridge, T.; Zhang, C.; Belagaje, R.; Stancato, L.; Dixon, J.; Johnson, B.; Bloem, L.; Pickard, T.; Donaghue, M.; et al. Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling. Biochem. Biophys. Res. Commun. 2001, 83, 1061-1068.
11. Zeng, Q.; Hong, W.; Tan, Y.H. Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1. Biochem. Biophys. Res. Commun. 1998, 244, 421-427.
12. Zeng, Q.; Dong, J.M.; Guo, K.; Li, J.; Tan, H.X.; Koh, V.; Pallen, C.J.; Manser, E.; Hong, W. PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Res. 2003, 63, 2716-2722.
13. Saha, S.; Bardelli, A.; Buckhaults, P.; Velculescu, V.E.; Rago, C., St.; Croix, B.; Romans, K.E.; Choti, M.A, Lengauer, C.; Kinzler, K.W.; Vogelstein, B. A Phosphatase Associated with Metastasis of Colorectal Cancer. Science 2001, 294, 1343-1346.
14. Guo, K.; Li, J.; Tang, J.P.; Koh, V.; Gan, B.Q.; Zeng, Q. Catalytic domain of PRL-3 plays an essential role in tumor metastasis: formation of PRL-3 tumors inside the blood vessels. Cancer Biol. Ther. 2004, 3, 945-951.
15. Kato, H.; Semba, S.; Miskad, U.A.; Seo, Y.; Kasuga, M.; Yokozaki, H. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases. Clin. Cancer Res. 2004, 10, 7318-7328.
16. Wu, X.; Zeng, H.; Zhang, X.; Zhao, Y.; Sha, H.; Ge, X.; Zhang, M.; Gao, X.; Xu, Q. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. Am. J. Pathol. 2004, 164, 2039-2054.
17. Parker, B.S.; Argani, P.; Cook, B.P.; Han, L.; Chartrand, S.D.; Zhang, M.; Saha, S.; Bardelli, A.; Jiang, Y.; Martin, T.B., St.; et al. Alterations in vascular gene expression in invasive breast carcinoma. Cancer Res. 2004, 64, 7857-7866.
18. Miskad, U.A.; Semba, S.; Kato, H.; Yokozaki, H. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis. Pathobiology 2004, 71, 176-184.
19. Li, Z.; Zhan, W.; Wang, Z.; Zhu, B.; He, Y.; Peng, J.; Cai, S.; Ma, J. Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis. Biochem. Biophys. Res. Commun. 2006, 348, 229-237.
20. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M.J. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58, 71-96.
21. Givant-Horwitz, V.; Davidson, B.; Goderstad, J.M.; Nesland, J.M.; Trope, C.G.; Reich, R. The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma. Gynecol. Oncol. 2004, 93, 517-523.
22. Givant-Horwitz, V.; Davidson, B.; Reich, R. Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor. Cancer Res. 2004, 64, 3572-3579.
23. Guidelines for Amplicon and Primer Design. The primers were designed according to guidelines from Tamar website using Primer 3 (as indicated by Tamar guidelines). Available online: http://www.tamar.co.il/site/item.php?ln=en&item_id=65&main_id=40 (accessed on 10 February 2011).
24. Lambert, C.A.; Colige, A.C.; Munaut, C.; Lapiere, C.M.; Nusgens, B.V. Distinct pathways in the over-expression of matrix metalloproteinases in human fibroblasts by relaxation of mechanical tension. Matrix Biol. 2001, 20, 397-408.
25. Reich, R.; Blumenthal, M.; Liscovitch, M. Role of phospholipase D in laminin-induced production of gelatinase A (MMP-2) in metastatic cells. Clin. Exp. Metastasis 1995, 13, 134-140.
26. Williger, B.T.; Reich, R.; Neeman, M.; Bercovici, T.; Liscovitch, M. Release of gelatinase A (matrix metalloproteinase 2) induced by photolysis of caged phosphatidic acid in HT 1080 metastatic fibrosarcoma cells. J. Biol. Chem. 1995, 270, 29656-29659.
27. Sager, J.; Benvenuti, S.; Bardelli, A. PRL-3: a phosphatase for metastasis? Cancer Biol. Ther. 2004, 3, 952-953.
28. Polato, F.; Codegoni, A.; Fruscio, R.; Perego, P.; Mangioni, C.; Saha, S.; Bardelli, A.; Broggini, M. PRL-3 phosphatase is implicated in ovarian cancer growth. Clin. Cancer Res. 2005, 11, 6835-6839.
29. Ren, T.; Jiang, B.; Xing, X.; Dong, B.; Peng, L.; Meng, L.; Xu, H.; Shou, C. Prognostic significance of phosphatase of regenerating liver-3 expression in ovarian cancer. Pathol. Oncol. Res. 2009, 15, 555-560.
30. Elloul, S.; Vaksman, O.; Stavnes, H.T.; Trope, C.G.; Davidson, B.; Reich, R. Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions. Clin. Exp. Metastasis 2010, 27, 161-172.
31. Wang, H.; Quah, S.Y.; Dong, J.M.; Manser, E.; Tang, J.P.; Zeng, Q. PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition. Cancer Res. 2007, 67, 2922-2926.
32. Peng, L.; Xing, X.; Li, W.; Qu, L.; Meng, L.; Lian, S.; Jiang, B.; Wu, J.; Shou, C. PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling. Mol. Cancer 2009, 8, 110.
33. Min, S.H.; Kim, D.M.; Heo, Y.S.; Kim, H.M.; Kim, I.C.; Yoo, O.J. Downregulation of p53 by phosphatase of regenerating liver 3 is mediated by MDM2 and PIRH2. Life Sci. 2010, 86, 66-72.